Intra-Cellular Therapies, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Intra-Cellular Therapies, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 106M shares, a 10% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 95.9M shares, a 1.95% increase from 2022.
  • Intra-Cellular Therapies, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 94M shares, a 15.7% increase from 2021.
  • Intra-Cellular Therapies, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 81.3M shares, a 15.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 106M +9.63M +10% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 104M +7.77M +8.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 96.9M +1.74M +1.83% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 95.9M +1.84M +1.95% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 96.1M +1.63M +1.72% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 95.9M +1.66M +1.76% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 95.1M +2.53M +2.73% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 94M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 94.5M +13.2M +16.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 94.3M +13.1M +16.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 92.6M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 81.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 81.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.